Saliladja, Sabriya T.
HRN: 23-34-10 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
04/07/2024
04/13/2024
IVT
4ml
TID
Age With Mod DHN
Checking Final Appropriateness
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes